Compare LTC & PBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LTC | PBH |
|---|---|---|
| Founded | 1992 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.4B |
| IPO Year | 1994 | 2004 |
| Metric | LTC | PBH |
|---|---|---|
| Price | $43.46 | $46.68 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 3 |
| Target Price | $40.00 | ★ $75.33 |
| AVG Volume (30 Days) | ★ 453.3K | 389.8K |
| Earning Date | 05-06-2026 | 05-08-2026 |
| Dividend Yield | ★ 5.96% | N/A |
| EPS Growth | ★ 23.53 | N/A |
| EPS | ★ 1.05 | 0.61 |
| Revenue | $262,854,000.00 | ★ $975,777,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $4.31 |
| P/E Ratio | ★ $40.26 | $76.97 |
| Revenue Growth | 25.26 | ★ 36.77 |
| 52 Week Low | $33.64 | $42.62 |
| 52 Week High | $43.16 | $71.07 |
| Indicator | LTC | PBH |
|---|---|---|
| Relative Strength Index (RSI) | 65.42 | 37.52 |
| Support Level | $37.67 | $47.61 |
| Resistance Level | $43.00 | $49.79 |
| Average True Range (ATR) | 0.75 | 1.39 |
| MACD | 0.17 | -0.62 |
| Stochastic Oscillator | 83.41 | 15.22 |
LTC Properties Inc is a real estate investment trust. It invests in seniors housing and health care properties, mainly through ownership, sale-leasebacks, mortgage financing, joint ventures, construction financing, and structured finance solutions, including preferred equity, bridge, and mezzanine lending. The company's investment portfolio comprises several properties located throughout the USA, the majority of which are seniors housing and skilled nursing properties. The firm conducts and manages its business as two operating segments: Real Estate Investments, which generates maximum revenue, and SHOP.
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.